Results 261 to 270 of about 935,849 (402)

Diagnosing acute lower respiratory tract infections in out-of-hours services during the COVID-19 pandemic. [PDF]

open access: yesInt J Emerg Med
Lindberg BH   +11 more
europepmc   +1 more source

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Polymyxins are used against highly resistant Gram‐negative pathogens, and nephrotoxicity (acute kidney injury, AKI) is the major dose‐limiting adverse effect. We aimed to develop a well‐informed population pharmacokinetic/toxicodynamic (PK/TD) model using the largest polymyxin B‐treated critically ill patient population studied to inform polymyxin B ...
Patrick O. Hanafin   +19 more
wiley   +1 more source

Simultaneous infections with different enteric and respiratory tract viruses

open access: bronze, 1986
Carl D. Brandt   +5 more
openalex   +1 more source

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez   +5 more
wiley   +1 more source

Evaluating the burden of respiratory tract infections among mortality cases in Karachi, Pakistan: a post-pandemic surveillance analysis. [PDF]

open access: yesJ Glob Health
Kabir F   +13 more
europepmc   +1 more source

The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.

open access: yesRespiratory Medicine, 2016
F. Blasi   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy